Warsaw/Prague, July 14, 2025 – Nencki Institute of Experimental Biology of the Polish Academy of Sciences has begun a collaboration with Czech biotech incubator and venture builder i&i Prague. This partnership, which builds on the long-standing relationship between the Nencki Institute and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, aims to support the development of a technology focused on creating a diagnostic test capable of detecting Alzheimer’s disease in its early stages.

The Nencki Institute of Experimental Biology is one of the foremost research institutes of the Polish Academy of Sciences, maintaining a long-standing focus on neuroscience and translational research in metabolic diseases. Through its interdisciplinary approach and international collaborations, the institute has successfully generated discoveries with strong application potential. The project concentrating on the early diagnosis of Alzheimer’s disease is the outcome of intensive research, which is now entering a new phase thanks to the support of i&i Prague.

“Our goal is to transform cutting-edge science into real benefits for society. The project aimed at the early detection of Alzheimer’s disease possesses not only high scientific value but also immense societal impact. Thanks to our collaboration with i&i Prague, we now have a genuine opportunity to bring this technology to patients – and that is our true motivation,” said Agnieszka Dobrzyń, Director of the Nencki Institute of Experimental Biology.

i&i Prague is a seasoned incubator focused on transferring scientific discoveries into practice. Founded around the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, it supports innovations in drug development, diagnostics, and medical technologies. The organization helps researchers transform their ideas into functioning companies, provides expert advice, connects them with investors and specialists, and guides them on the journey from lab to real-world patients.

“Alzheimer’s disease is one of the greatest challenges of modern medicine, yet no reliable tool for its early detection exists today. The project initiated at the Nencki Institute brings hope for change. We are proud to support the research team in transforming this discovery into a real product,” said Iva Machová, Incubation Manager and Regional Manager for Poland at i&i Prague. “We believe that the incubation of this project is just the beginning of a long journey that will help unique Polish scientific ideas to find their way from the lab to the market,” she added.